Firethorn Wealth Partners’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Firethorn Wealth Partners’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-21,705	Closed	-$145K	–	153
2023 Q3	$145K	Sell	21,705 -700	-3%	-$5.82K	0.11%	114
2023 Q2	$203K	Sell	22,405 -4,975	-18%	-$43.9K	0.15%	110
2023 Q1	$207K	Sell	27,380 -8,525	-24%	-$63.2K	0.16%	107
2022 Q4	$262K	Buy	35,905 +200	+0.6%	+$1.48K	0.22%	96
2022 Q3	$276K	Sell	35,705 -1,525	-4%	-$12.9K	0.26%	88
2022 Q2	$271K	Buy	37,230 +3,480	+10%	+$26.6K	0.22%	95
2022 Q1	$269K	Buy	33,750 +2,050	+6%	+$13K	0.2%	99
2021 Q4	$178K	Buy	+31,700	New	+$238K	0.13%	132
2021 Q2	$303K	Buy	+29,485	New	+$300K	0.25%	87

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Firethorn Wealth Partners's PNT Position: Q4 2023 in Review

Firethorn Wealth Partners sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 21,705 shares — an estimated $145K sold.

Firethorn Wealth Partners first reported a position in PNT in Q2 2021 and held it in 9 quarters. The position peaked at $303K in Q2 2021. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Firethorn Wealth Partners reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Firethorn Wealth Partners sold 21,705 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $145K.
Firethorn Wealth Partners first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2021 and held it in 9 quarters.
Firethorn Wealth Partners's POINT Biopharma Global Inc. Common Stock position peaked at $303K in Q2 2021.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Firethorn Wealth Partners's 13F filing for Q4 2023, filed 25 Jan 2024.